|
CCDC75 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.619200E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.46870000000832E-05 |
| Normal-vs-Stage2 |
1.450560E-01 |
| Normal-vs-Stage3 |
3.238800E-01 |
| Normal-vs-Stage4 |
1.506150E-01 |
| Stage1-vs-Stage2 |
4.660000E-01 |
| Stage1-vs-Stage3 |
7.540200E-02 |
| Stage1-vs-Stage4 |
8.298400E-01 |
| Stage2-vs-Stage3 |
5.228800E-01 |
| Stage2-vs-Stage4 |
7.944400E-01 |
| Stage3-vs-Stage4 |
4.001400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.815950E-04 |
| Normal-vs-AfricanAmerican |
4.600000E-03 |
| Normal-vs-Asian |
7.942000E-01 |
| Caucasian-vs-AfricanAmerican |
8.526400E-01 |
| Caucasian-vs-Asian |
3.501400E-01 |
| AfricanAmerican-vs-Asian |
4.043000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.11920000001042E-06 |
| Normal-vs-Female |
9.920000E-01 |
| Male-vs-Female |
4.13089999999894E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.966100E-04 |
| Normal-vs-Extreme_Weight |
1.26529999999736E-06 |
| Normal-vs-Obese |
9.465800E-02 |
| Normal-vs-Extreme_Obese |
3.415600E-03 |
| Normal_Weight-vs-Extreme_Weight |
3.111000E-01 |
| Normal_Weight-vs-Obese |
9.660200E-02 |
| Normal_Weight-vs-Extreme_Obese |
8.110600E-01 |
| Extreme_Weight-vs-Obese |
2.960600E-03 |
| Extreme_Weight-vs-Extreme_Obese |
7.382200E-01 |
| Obese-vs-Extreme_Obese |
2.432200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.430400E-01 |
| Normal-vs-Age(41-60Yrs) |
7.018200E-03 |
| Normal-vs-Age(61-80Yrs) |
4.1991000000019E-05 |
| Normal-vs-Age(81-100Yrs) |
4.22050000000729E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.448800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.361900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.851800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.325180E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.292290E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.840200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.84540000000866E-06 |
| Normal-VS-Type2 PRCC |
9.005700E-02 |
| Normal-VS-KIRP CIMP |
6.639400E-01 |
| Normal-VS-Unclassified PRCC |
7.006800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.576200E-03 |
| Type1 PRCC-VS-KIRP CIMP |
1.655800E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
1.298380E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.039200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.307800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.603000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.795800E-04 |
| Normal-vs-N1 |
9.203400E-01 |
| Normal-vs-N2 |
1.129050E-01 |
| N0-vs-N1 |
2.293600E-02 |
| N0-vs-N2 |
8.716200E-01 |
| N1-vs-N2 |
4.065600E-01 |
|
|
